Neuromedin U-25 human is the active form of neuromedin U in human. Neuromedin U-25 human inhibits glucose-stimulated insulin secretion, which leads to early-onset obesity. Neuromedin U-25 serves as vasoconstrictor in human vascular beds.

Pulsatilla saponin D has exhibited potential beneficial effects as a chemopreventive agent for critical health conditions including cancer and it inhibits cell growth via cell cycle arrest and apoptosis in various cancer cell types.

2-Methoxyethanol is used in the synthesis of 2-aminothiazoles in the treatment of prion disease. 2-Methoxyethanol is also used in the preparation of Rho-associated kinase inhibitors or (ROCK) inhibitors for the treatment of cardiovascular disease.